Pricing
Login
Home
Charts
Search
Watchlist
Products

Blue Jet Healthcare Ltd

BLUEJET
₹517.60+0.15%20 Nov 2026
Reports
Pharma CRAMS

Blue Jet Healthcare Ltd

BLUEJET
₹517.60
+0.15%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹9,797Cr
Close
Close Price
₹517.60
Industry
Industry
Pharma CRAMS
PE
Price To Earnings
32.35
PS
Price To Sales
8.94
Revenue
Revenue
₹1,096Cr
Rev Gr TTM
Revenue Growth TTM
-7.05%
PAT Gr TTM
PAT Growth TTM
-19.04%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
167184163208318340355165192235293376
Growth YoY
Revenue Growth YoY%
-1.3-15.3-9.314.890.985.1117.8-20.5-39.6-31.1-17.4127.1
Expenses
ExpensesCr
112131119139194200234111146163195257
Operating Profit
Operating ProfitCr
5553446912414012155477198119
OPM
OPM%
32.728.927.233.439.041.134.133.224.430.433.531.6
Other Income
Other IncomeCr
-39912131282413231526
Interest Expense
Interest ExpenseCr
000000150111
Depreciation
DepreciationCr
883555666677
PBT
PBTCr
44544977132147123695487106137
Tax
TaxCr
121512193437321714232835
PAT
PATCr
32403858991109152406478103
Growth YoY
PAT Growth YoY%
-14.4-21.8-14.421.9208.3177.7141.3-10.6-59.4-41.6-14.296.6
NPM
NPM%
19.321.623.228.031.132.325.731.520.927.426.727.3
EPS
EPS₹
1.92.32.23.45.76.35.33.02.33.74.55.5
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
167184163208318340355165192235293376
Growth YoY
Revenue Growth YoY%
-1.3-15.3-9.314.890.985.1117.8-20.5-39.6-31.1-17.4127.1
Expenses
ExpensesCr
112131119139194200234111146163195257
Operating Profit
Operating ProfitCr
5553446912414012155477198119
OPM
OPM%
32.728.927.233.439.041.134.133.224.430.433.531.6
Other Income
Other IncomeCr
-39912131282413231526
Interest Expense
Interest ExpenseCr
000000150111
Depreciation
DepreciationCr
883555666677
PBT
PBTCr
44544977132147123695487106137
Tax
TaxCr
121512193437321714232835
PAT
PATCr
32403858991109152406478103
Growth YoY
PAT Growth YoY%
-14.4-21.8-14.421.9208.3177.7141.3-10.6-59.4-41.6-14.296.6
NPM
NPM%
19.321.623.228.031.132.325.731.520.927.426.727.3
EPS
EPS₹
1.92.32.23.45.76.35.33.02.33.74.55.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5384996837217121,0309471,096
Growth
Revenue Growth%
-7.337.05.5-1.344.7-8.0-7.0
Expenses
ExpensesCr
325292434502482652653761
Operating Profit
Operating ProfitCr
214207249219229378294335
OPM
OPM%
39.741.436.530.432.236.731.130.6
Other Income
Other IncomeCr
69192419466978
Interest Expense
Interest ExpenseCr
75310062
Depreciation
DepreciationCr
1820222528182426
PBT
PBTCr
194190243217220406333384
Tax
TaxCr
49496257561018599
PAT
PATCr
145142182160164305248285
Growth
PAT Growth%
-2.128.2-11.92.386.4-18.8-19.0
NPM
NPM%
26.928.426.622.223.029.626.226.0
EPS
EPS₹
1,461.21,428.610.59.29.417.614.316.0
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
5384996837217121,0309471,096
Growth
Revenue Growth%
-7.337.05.5-1.344.7-8.0-7.0
Expenses
ExpensesCr
325292434502482652653761
Operating Profit
Operating ProfitCr
214207249219229378294335
OPM
OPM%
39.741.436.530.432.236.731.130.6
Other Income
Other IncomeCr
69192419466978
Interest Expense
Interest ExpenseCr
75310062
Depreciation
DepreciationCr
1820222528182426
PBT
PBTCr
194190243217220406333384
Tax
TaxCr
49496257561018599
PAT
PATCr
145142182160164305248285
Growth
PAT Growth%
-2.128.2-11.92.386.4-18.8-19.0
NPM
NPM%
26.928.426.622.223.029.626.226.0
EPS
EPS₹
1,461.21,428.610.59.29.417.614.316.0
Sales CAGR
1 Year-8%
3 Years10%
5 Years14%
TTM-7%
EBITDA CAGR
1 Year-22%
3 Years10%
5 Years7%
TTM-24%
PAT CAGR
1 Year-19%
3 Years16%
5 Years12%
TTM-19%
Avg. ROCE
1 Year24%
3 Years28%
5 Years33%
TTM17%
CFO / EBITDA
1 Year114%
3 Years69%
5 Years66%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
110353535353538
Reserves
ReservesCr
1883304876478111,0981,3252,261
Current Liabilities
Current LiabilitiesCr
127160175174206256227233
Non Current Liabilities
Non Current LiabilitiesCr
39331778295453
Total Liabilities
Total LiabilitiesCr
3645347138621,0591,4181,6412,584
Current Assets
Current AssetsCr
2483895486657061,0069571,796
Non Current Assets
Non Current AssetsCr
116144165197353412684788
Total Assets
Total AssetsCr
3645347138621,0591,4181,6412,584
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
110353535353538
Reserves
ReservesCr
1883304876478111,0981,3252,261
Current Liabilities
Current LiabilitiesCr
127160175174206256227233
Non Current Liabilities
Non Current LiabilitiesCr
39331778295453
Total Liabilities
Total LiabilitiesCr
3645347138621,0591,4181,6412,584
Current Assets
Current AssetsCr
2483895486657061,0069571,796
Non Current Assets
Non Current AssetsCr
116144165197353412684788
Total Assets
Total AssetsCr
3645347138621,0591,4181,6412,584

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
12213714614224146334
Investing Cash Flow
Investing Cash FlowCr
-45-61-76-147-264-35-276
Financing Cash Flow
Financing Cash FlowCr
-73-21-56-4-2-19-31
Net Cash Flow
Net Cash FlowCr
55514-10-24-828
Free Cash Flow
Free Cash FlowCr
1061021268369-34115
CFO To PAT
CFO To PAT%
84.696.680.688.5147.315.0134.8
CFO To EBITDA
CFO To EBITDA%
57.366.258.764.6105.312.1113.6
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
12213714614224146334
Investing Cash Flow
Investing Cash FlowCr
-45-61-76-147-264-35-276
Financing Cash Flow
Financing Cash FlowCr
-73-21-56-4-2-19-31
Net Cash Flow
Net Cash FlowCr
55514-10-24-828
Free Cash Flow
Free Cash FlowCr
1061021268369-34115
CFO To PAT
CFO To PAT%
84.696.680.688.5147.315.0134.8
CFO To EBITDA
CFO To EBITDA%
57.366.258.764.6105.312.1113.6

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6,63415,2785,6779,797
Price To Earnings
Price To Earnings
40.550.122.932.4
Price To Sales
Price To Sales
9.314.86.08.9
Price To Book
Price To Book
7.813.54.24.3
EV To EBITDA
EV To EBITDA
28.640.218.928.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
54.558.649.243.947.748.646.246.2
OPM
OPM%
39.741.436.530.432.236.731.130.6
NPM
NPM%
26.928.426.622.223.029.626.226.0
ROCE
ROCE%
83.852.145.831.826.035.224.216.8
ROE
ROE%
76.641.734.823.519.426.918.212.4
ROA
ROA%
39.726.525.518.615.521.515.111.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
6,63415,2785,6779,797
Price To Earnings
Price To Earnings
40.550.122.932.4
Price To Sales
Price To Sales
9.314.86.08.9
Price To Book
Price To Book
7.813.54.24.3
EV To EBITDA
EV To EBITDA
28.640.218.928.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
54.558.649.243.947.748.646.246.2
OPM
OPM%
39.741.436.530.432.236.731.130.6
NPM
NPM%
26.928.426.622.223.029.626.226.0
ROCE
ROCE%
83.852.145.831.826.035.224.216.8
ROE
ROE%
76.641.734.823.519.426.918.212.4
ROA
ROA%
39.726.525.518.615.521.515.111.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr26,48318,45518,2349,7975,5952,7221,984
Close PriceClose₹20,642.001,609.30451.70517.60977.80220.76961.25
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE58.5297.5632.3533.5630.41
Price To SalesPS11.4810.965.188.943.001.472.19
RevenueRevenueCr2,3071,6843,5221,0961,8651,851904
Revenue Growth TTMRev Gr TTM%50.5%10.7%-6.0%-7.0%36.8%8.9%19.0%
PAT Growth TTMPAT Gr TTM%88.4%-104.1%-60.3%-19.0%34.0%-149.5%8.9%
Market CapitalizationMkt CapCr26,48318,45518,2349,7975,5952,7221,984
Close PriceClose₹20,642.001,609.30451.70517.60977.80220.76961.25
IndustryIndustryPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMSPharma CRAMS
Price To EarningsPE58.5297.5632.3533.5630.41
Price To SalesPS11.4810.965.188.943.001.472.19
RevenueRevenueCr2,3071,6843,5221,0961,8651,851904
Revenue Growth TTMRev Gr TTM%50.5%10.7%-6.0%-7.0%36.8%8.9%19.0%
PAT Growth TTMPAT Gr TTM%88.4%-104.1%-60.3%-19.0%34.0%-149.5%8.9%